SALT LAKE CITY, Feb. 8, 2022 — Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its participation in the following upcoming investor conferences:
SVB Leerink 11th Annual Global Healthcare Conference — Monday, February 14 through Friday, February 18, 2022
About The Company
Recursion is the clinical-stage biotechnology company industrializing drug discovery by decoding biology. Enabling its mission is the companies Operating System, a platform built across diverse technologies that continuously expands one of the world’s largest proprietary biological and chemical datasets, the companies Data Universe.
Recursion leverages sophisticated machine-learning algorithms to distill from its dataset the Company Map, a collection of hundreds of billions of searchable inferences across biology and chemistry unconstrained by human bias.
By commanding massive experimental scale up to millions of wet lab experiments weekly — and massive computational scale owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
The company is proudly headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. The Company also has offices in Toronto, Montréal and the San Francisco Bay Area.
Image Courtesy Recursion
This article was shared with Prittle Prattle News as a Press Release by PRNewswire
